Des études vont tester l’hydroxychloroquine (ou la chloroquine) en prévention chez les soignants.
Une étude va évaluer l’hydroxychloroquine et l’azithromycine [séparément] en prévention du #Covid-19
▻https://www.nouvelobs.com/coronavirus-de-wuhan/20200414.OBS27501/l-hydroxychloroquine-peut-elle-empecher-d-attraper-le-covid-19.html
Ses résultats sont attendus dans environ « 70 jours », a expliqué à l’AFP son responsable, le Pr Jean-Marc Tréluyer, de l’Unité de recherche clinique Necker-Cochin (AP-HP/Université de Paris).
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers - Full Text View - ClinicalTrials.gov
▻https://clinicaltrials.gov/ct2/show/NCT04333225
(Dallas, Texas)
In order to assess the efficacy of hydroxychloroquine treatment weekly for a total of 7 weeks in the prevention of COVID-19 infection, three hundred sixty (360) Healthcare workers with high risk exposure to patients infected with COVID-19 will be tested for COVID-19 infection via nasopharyngeal (NP) swab once weekly for 7 weeks. Of those, one hundred eighty (180) will receive weekly doses of hydroxychloroquine for the duration of the study. Subjects who opt not to receive the study drug will form the control group.
Et une autre, beaucoup plus longue sur 1 an, en Afrique et en Asie
Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting - Full Text View - ClinicalTrials.gov
▻https://clinicaltrials.gov/ct2/show/NCT04303507